Paul Averback
Chief Executive Officer at NYMOX PHARMACEUTICAL CORPORATION
Net worth: 20 M $ as of 2023-09-29
Profile
Paul Averback has founded Nymox Pharmaceutical Corp.
in 1995, where he holds the titles of Chairman, President & Chief Executive Officer.
He has also worked as the President of DMS Pharmaceutical Group, Inc. Dr. Averback earned a doctorate degree from the University of Cambridge in 1975.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NYMOX PHARMACEUTICAL CORP
42.22% | 2023-04-18 | 38,533,010 ( 42.22% ) | 20 M $ | 2023-09-29 |
Paul Averback active positions
| Companies | Position | Start |
|---|---|---|
| NYMOX PHARMACEUTICAL CORPORATION | Chief Executive Officer | 1995-09-19 |
Former positions of Paul Averback
| Companies | Position | End |
|---|---|---|
DMS Pharmaceutical Group, Inc.
 DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services DMS Pharmaceutical Group, Inc. supplies pharmaceutical products. Its distribution system and online communications platform gives their customers access to inventories, information and databases. The company was founded by Sam Lazich and Angie Lazich in 1995 and is headquartered in Park Ridge, IL. | President | - |
Training of Paul Averback
| University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NYMOX PHARMACEUTICAL CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
DMS Pharmaceutical Group, Inc.
DMS Pharmaceutical Group, Inc. Medical DistributorsDistribution Services DMS Pharmaceutical Group, Inc. supplies pharmaceutical products. Its distribution system and online communications platform gives their customers access to inventories, information and databases. The company was founded by Sam Lazich and Angie Lazich in 1995 and is headquartered in Park Ridge, IL. | Distribution Services |
- Stock Market
- Insiders
- Paul Averback
